Aspira Women's Health Inc.
AWHLOTCHealthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $9.2M | $9.2M | $9.2M | $8.2M | $6.8M | $4.7M |
| Operating income | −$7.9M | −$16.3M | −$18.9M | −$31.1M | −$32.6M | −$18.0M |
| Net income | −$12.8M | −$13.1M | −$16.7M | −$29.9M | −$31.7M | −$17.9M |
| Total assets | $5.5M | $5.5M | $6.3M | $17.4M | $41.1M | $19.6M |
| Total liabilities | $12.4M | $8.1M | $8.6M | $10.4M | $10.9M | $9.9M |
| Equity | −$6.9M | −$2.6M | −$2.4M | $7.0M | $30.2M | $9.7M |
| EPS (diluted) | $-0.37 | $-0.93 | $-1.81 | $-3.85 | $-0.28 | $-0.18 |
| Shares out. | 29.8M | 12.3M | 124.9M | 112.1M | 111.7M | 97.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −85.9%
- Net margin
- −138.7%
- Return on equity
- 184.4%
- Return on assets
- −234.2%
- Return on capital (ROCE)
- −397.4%
- Liabilities / assets
- 227.1%
- Debt / equity
- —
- Book value / share
- $-0.23
- Revenue growth (YoY)
- 0.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -334.76distress
- Accruals / assets
- −105.4%clean
- Beneish M-Score
- -7.32normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2026
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Schuler Jack WActivist (13D)Sep 19, 2025
- Armistice Capital, LlcPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 8,994 | 1.0 | +60.2% |
| Apr 30, 2026 | 5,615 | 1.0 | +4.6% |
| Apr 15, 2026 | 5,367 | 1.0 | -2.4% |
| Mar 31, 2026 | 5,498 | 1.0 | -50.2% |
| Mar 13, 2026 | 11,046 | 1.0 | +49.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementMay 26, 2026
- Director / officer changeApr 30, 2026
- Entered a material agreement · New financial obligationJan 30, 2026
- Regulation FD disclosureDec 31, 2025
- Entered a material agreement · Unregistered equity saleDec 23, 2025
- Entered a material agreementDec 22, 2025
- Results of operationsNov 14, 2025
- Other material eventOct 15, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.